Another recent study highlighted the involvement of PVRIG/PVRL2 axis in AML and suggested that PVRIG blockade may be a novel approach to enhance NK cell activity in PVRL2+ AML (57). This evidence concerns the gene PVRIG and acute myeloid leukemia.